Literature DB >> 7730481

Iron metabolism and fungal infections in patients with haematological malignancies.

C Iglesias-Osma1, L Gonzalez-Villaron, J F San Miguel, M D Caballero, L Vazquez, S de Castro.   

Abstract

AIM: To determine whether iron metabolism influences the incidence of systemic fungal infection in patients with haematological malignancies.
METHODS: The study population comprised 74 patients who had undergone myeloablative chemotherapy. Systemic fungal infections were classified as confirmed (histological confirmation or characteristic septate hyphae) or possible (antibiotic resistant fever which resolved following administration of intravenous amphotericin B, together with either typical radiographic lesions or massive oropharyngeal candidiasis). Parameters of iron metabolism included serum iron concentrations, total iron binding capacity, serum transferrin, and ferritin concentrations and transferrin saturation values.
RESULTS: Patients who developed a fungal infection had substantially increased transferrin saturation values and ferritin concentrations at diagnosis together with low serum transferrin and high serum iron concentrations. This profile was present in patients with a fungal infection regardless of the underlying haematological disorder.
CONCLUSION: Increased transferrin saturation values and high ferritin concentrations may be additional risk factors for the development of systemic fungal infection in patients with haematological malignancies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730481      PMCID: PMC502449          DOI: 10.1136/jcp.48.3.223

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Quantitation of ferritin iron in plasma, an explanation for non-transferrin iron.

Authors:  P Pootrakul; B Josephson; H A Huebers; C A Finch
Journal:  Blood       Date:  1988-04       Impact factor: 22.113

2.  Effects of iron and desferrioxamine on Rhizopus infection.

Authors:  F Abe; H Inaba; T Katoh; M Hotchi
Journal:  Mycopathologia       Date:  1990-05       Impact factor: 2.574

3.  Transferrin in disease II: defects in the regulation of transferrin saturation with iron contribute to susceptibility to infection.

Authors:  R L Hunter; B Bennett; M Towns; W R Vogler
Journal:  Am J Clin Pathol       Date:  1984-06       Impact factor: 2.493

4.  [Ferritin in acute leukemia. Serum ferritin concentration as a nonspecific tumor marker for M1 and M2 myeloid leukemia].

Authors:  E Aulbert; H Fromm; H Hornemann
Journal:  Med Klin (Munich)       Date:  1991-06-15

5.  Serum ferritin and Hodgkin's disease.

Authors:  W R Bezwoda; D P Derman; T H Bothwell; R Baynes; C Hesdorffer; A P MacPhail
Journal:  Scand J Haematol       Date:  1985-11

Review 6.  Intestinal mucormycosis in a hemodialysis patient treated with desferrioxamine.

Authors:  T Kaneko; F Abe; M Ito; M Hotchi; K Yamada; Y Okada
Journal:  Acta Pathol Jpn       Date:  1991-07

7.  Siderophore production by the pathogenic yeast, Candida albicans.

Authors:  A Ismail; G W Bedell; D M Lupan
Journal:  Biochem Biophys Res Commun       Date:  1985-07-31       Impact factor: 3.575

8.  Association of reduced total iron binding capacity and fungal infections in leukemic granulocytopenic patients.

Authors:  J E Karp; W G Merz
Journal:  J Clin Oncol       Date:  1986-02       Impact factor: 44.544

9.  Hydroxamate siderophore production by opportunistic and systemic fungal pathogens.

Authors:  M Holzberg; W M Artis
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

10.  The measurement of ferritin in the leukemic blasts with a "sandwich" type enzyme immunoassay method.

Authors:  M Tanaka; K Kato
Journal:  Cancer       Date:  1983-01-01       Impact factor: 6.860

View more
  12 in total

1.  Iron acquisition from transferrin by Candida albicans depends on the reductive pathway.

Authors:  Simon A B Knight; Gaston Vilaire; Emmanuel Lesuisse; Andrew Dancis
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 2.  Targeting immunometabolism in host-directed therapies to fungal disease.

Authors:  Samuel M Gonçalves; Anaísa V Ferreira; Cristina Cunha; Agostinho Carvalho
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

3.  Survival of Aspergillus fumigatus in serum involves removal of iron from transferrin: the role of siderophores.

Authors:  A H T Hissen; J M T Chow; L J Pinto; M M Moore
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

4.  Iron overload in patients undergoing hematopoietic stem cell transplantation.

Authors:  Vinod Pullarkat
Journal:  Adv Hematol       Date:  2010-09-08

Review 5.  Lessons about the pathogenesis and management of aspergillosis from studies in chronic granulomatous disease.

Authors:  John I Gallin; Kol Zarember
Journal:  Trans Am Clin Climatol Assoc       Date:  2007

Review 6.  Iron: an essential nutrient for Aspergillus fumigatus and a fulcrum for pathogenesis.

Authors:  Efthymia I Matthaiou; Gabriele Sass; David A Stevens; Joe L Hsu
Journal:  Curr Opin Infect Dis       Date:  2018-12       Impact factor: 4.915

7.  Host iron withholding demands siderophore utilization for Candida glabrata to survive macrophage killing.

Authors:  Tracy Nevitt; Dennis J Thiele
Journal:  PLoS Pathog       Date:  2011-03-17       Impact factor: 6.823

Review 8.  Iron at the Centre of Candida albicans Interactions.

Authors:  Ruan Fourie; Oluwasegun O Kuloyo; Bonang M Mochochoko; Jacobus Albertyn; Carolina H Pohl
Journal:  Front Cell Infect Microbiol       Date:  2018-06-05       Impact factor: 5.293

9.  Elevation of serum ferritin is associated with the outcome of patients with newly diagnosed multiple myeloma.

Authors:  Moo-Kon Song; Joo-Seop Chung; Young-Mi Seol; Ho-Jin Shin; Young-Jin Choi; Goon-Jae Cho
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 2.884

Review 10.  Conflicting interests in the pathogen-host tug of war: fungal micronutrient scavenging versus mammalian nutritional immunity.

Authors:  Joanna Potrykus; Elizabeth R Ballou; Delma S Childers; Alistair J P Brown
Journal:  PLoS Pathog       Date:  2014-03-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.